Fenfluramine for treating seizures associated with Dravet syndrome
Technology appraisal guidance
Reference number: TA808
Published:
The company have asked NICE to reschedule this appraisal again to better align with the regulatory process and NICE has agreed to this request.
We anticipate that the appraisal will now re-start in Spring 2020.